Jubilant HollisterStier Growth Pushes to Lead Spokane


Enough shots for every American. That could be the result of the ongoing expansion at Jubilant HollisterStier, according to CEO and president Chris Preti who spoke last week to other manufacturers at Life Science Washington’s East West Life Science Summit held at Washington State University’s Spokane campus.

Jubilant specializes in producing injectable products for pharmaceutical and biotech companies. At one point in time, it was the only firm making coronavirus vaccines in Washington. In February, the firm announced the completion of the first phase of an expansion project to add a third production line in their facility at 3525 N. Regal St. The second and final phase is to add a fourth line. When complete, the firm will be well suited to supply Americans with vaccines – every American, that is.